In addition to this, DGCR5 downregulation is found to significantly correlate with the poor prognosis of lung cancer patients (Chen et al., 2017; Luo et al., 2018) and the aggressive clinical features in gastric cancer patients (Xu et al., 2019). This evidence concerns the gene DGCR5 and lung cancer.